Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > MISCELLANEOUS > News - Lasa Supergenerics

Lasa Supergenerics

BSE: 540702|NSE: LASA|ISIN: INE670X01014|SECTOR: Miscellaneous
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 08, 16:00
33.30
0.95 (2.94%)
VOLUME 19,459
LIVE
NSE
Apr 08, 15:58
32.45
1.5 (4.85%)
VOLUME 8,606
News on Lasa Supergenerics
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Lasa Supergenerics, ICT to co-develop antiviral drug favipiravir to combat COVID-19

8.55 pm | 16 Mar 2020 |  Source: Moneycontrol.com

The drug, a broadspectrum antiviral medication, is not protected by any patents in India....

1 2
Quick Links for Lasa Supergenerics
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.